Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $4.5 million.

  • Tandem Diabetes Care's Depreciation & Amortization (CF) rose 669.67% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year increase of 624.05%. This contributed to the annual value of $16.6 million for FY2024, which is 567.61% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Depreciation & Amortization (CF) of $4.5 million as of Q3 2025, which was up 669.67% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Depreciation & Amortization (CF) ranged from a high of $4.5 million in Q3 2025 and a low of $3.4 million during Q1 2023
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $4.0 million (2023), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Tandem Diabetes Care's Depreciation & Amortization (CF) skyrocketed by 9043.72% in 2021, and later plummeted by 639.47% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Depreciation & Amortization (CF) (Quarter) stood at $3.5 million in 2021, then rose by 3.44% to $3.6 million in 2022, then grew by 10.71% to $4.0 million in 2023, then rose by 5.31% to $4.2 million in 2024, then rose by 5.84% to $4.5 million in 2025.
  • Its Depreciation & Amortization (CF) was $4.5 million in Q3 2025, compared to $4.4 million in Q2 2025 and $4.3 million in Q1 2025.